Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126493401 | 12649340 | 1 | I | 2001 | 20160802 | 20160812 | 20160812 | EXP | US-PRINSTON PHARMACEUTICAL INC.-2016PRN00200 | PRINSTON PHARMACEUTICAL | 0.00 | M | Y | 185.94000 | KG | 20160811 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126493401 | 12649340 | 1 | PS | BENAZEPRIL HYDROCHLORIDE. | BENAZEPRIL HYDROCHLORIDE | 1 | 20 MG, 1X/DAY | 76118 | 20 | MG | TABLET | QD | |||||||
| 126493401 | 12649340 | 2 | SS | BENAZEPRIL HYDROCHLORIDE. | BENAZEPRIL HYDROCHLORIDE | 1 | 40 MG, 1X/DAY | 76118 | 40 | MG | TABLET | QD | |||||||
| 126493401 | 12649340 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | M66475 | 0 | 100 | MG | CAPSULE | TID | |||||
| 126493401 | 12649340 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
| 126493401 | 12649340 | 5 | C | DIAZEPAM. | DIAZEPAM | 1 | 10 MG, UNK | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126493401 | 12649340 | 1 | Blood pressure measurement |
| 126493401 | 12649340 | 3 | Neuropathy peripheral |
| 126493401 | 12649340 | 4 | Gout |
| 126493401 | 12649340 | 5 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126493401 | 12649340 | HO |
| 126493401 | 12649340 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126493401 | 12649340 | Blood cholesterol increased | |
| 126493401 | 12649340 | Cardiac failure congestive | |
| 126493401 | 12649340 | Cardiovascular disorder | |
| 126493401 | 12649340 | Cellulitis | |
| 126493401 | 12649340 | Chronic obstructive pulmonary disease | |
| 126493401 | 12649340 | Cognitive disorder | |
| 126493401 | 12649340 | Dyspnoea | |
| 126493401 | 12649340 | Fluid retention | |
| 126493401 | 12649340 | Hypertension | |
| 126493401 | 12649340 | Infection | |
| 126493401 | 12649340 | Neuropathy peripheral | |
| 126493401 | 12649340 | Peripheral swelling | |
| 126493401 | 12649340 | Pneumonia | |
| 126493401 | 12649340 | Pulmonary congestion | |
| 126493401 | 12649340 | Sleep disorder | |
| 126493401 | 12649340 | Unevaluable event | |
| 126493401 | 12649340 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126493401 | 12649340 | 1 | 2001 | 0 | ||
| 126493401 | 12649340 | 4 | 2001 | 0 | ||
| 126493401 | 12649340 | 5 | 1993 | 0 |